Atlas Trials

Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver

Clinical trial NCT02885753 · RECRUITING

Trial details

NCT number
NCT02885753
Sponsor
Federation Francophone de Cancerologie Digestive
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Colorectal Neoplasms
Start date
2016-12-01
Primary completion
2028-09-01
Enrollment
348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.